Epigenomics AG (STU:ECX) Change In Inventory : €0.08 Mil (TTM As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Epigenomics AG Change In Inventory?

Epigenomics AG's change in inventory for the quarter that ended in Jun. 2023 was €0.00 Mil. It means Epigenomics AG's inventory stayed the same from Mar. 2023 to Jun. 2023 .

Epigenomics AG's change in inventory for the fiscal year that ended in Dec. 2022 was €0.12 Mil. It means Epigenomics AG's inventory declined by €0.12 Mil from Dec. 2021 to Dec. 2022 .

Epigenomics AG's Total Inventories for the quarter that ended in Jun. 2023 was €0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Epigenomics AG's Days Inventory for the quarter that ended in Jun. 2023 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Epigenomics AG's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.00.

Epigenomics AG Change In Inventory Historical Data

The historical data trend for Epigenomics AG's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epigenomics AG Change In Inventory Chart

Epigenomics AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Inventory

Get a 7-Day Free Trial

-0.07

0.05

0.19

-0.05

0.12

Epigenomics AG Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Change In Inventory	Get a 7-Day Free Trial															0.04	-0.14	0.15	0.06	-

Epigenomics AG Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.08 Mil.

Epigenomics AG (STU:ECX) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Epigenomics AG's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0.005	*	365 / 4
	=	0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Epigenomics AG's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.005	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Epigenomics AG's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0.07
	=	0.00

Epigenomics AG Change In Inventory Related Terms

Thank you for viewing the detailed overview of Epigenomics AG's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Epigenomics AG (STU:ECX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Epigenomics AG (STU:ECX) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

EPGNF:USA

Address

Geneststrasse 5, Berlin, BB, DEU, 10829

Website

https://www.epigenomics.com

Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.